Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.20.1
Document and Entity Information
3 Months Ended
Mar. 31, 2020
shares
Document and Entity Information  
Document Type 10-Q
Document Period End Date Mar. 31, 2020
Entity Registrant Name EYEGATE PHARMACEUTICALS INC
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Small Business true
Entity Emerging Growth Company true
Entity Ex Transition Period true
Entity Shell Company false
Entity Common Stock, Shares Outstanding 4,626,755
Entity Central Index Key 0001372514
Current Fiscal Year End Date --12-31
Document Fiscal Year Focus 2020
Document Fiscal Period Focus Q1
Amendment Flag false
Trading Symbol EYEG